UVA Health: Monoclonal Antibody Targets Deadly Sepsis
August 15, 2025
August 15, 2025
CHARLOTTESVILLE, Virginia, Aug. 15 (TNSjou) -- University of Virginia Health issued the following news release:
* * *
New Monoclonal Antibody Targets Deadly Sepsis
Scientists at the University of Virginia School of Medicine and the University of Michigan have developed a monoclonal antibody to stop sepsis, a deadly full-body infection. The antibody also has the potential to treat a broad array of other inflammatory conditions, including autoimmune disorders . . .
* * *
New Monoclonal Antibody Targets Deadly Sepsis
Scientists at the University of Virginia School of Medicine and the University of Michigan have developed a monoclonal antibody to stop sepsis, a deadly full-body infection. The antibody also has the potential to treat a broad array of other inflammatory conditions, including autoimmune disorders . . .